Altre lingue Novo Nordisk A/S

Azioni

NOVO B

DK0062498333

Prodotti farmaceutici

Tempo reale stimato Cboe Europe Altri mercati azionari 13:11:18 20/06/2025			Variaz. 5gg	Var. 1 gen.
478,28 ^DKK	-2,07%		-7,38%	-23,41%

10:52	Eli Lilly: Risposta positiva in India per il farmaco anti-obesità Mounjaro, focus sulla domanda crescente	RE
10:20	United Laboratories International: United Biotechnology Riceve Pagamento Anticipato da Novo Nordisk	RE

Altre lingue

Eli Lilly says India response to obesity drug Mounjaro is 'positive', will focus on meeting demand	10:52
United Laboratories International Says United Biotechnology Got Upfront Payment From Novo Nordisk	10:20
United Laboratories Unit Gets $180 Million Upfront Payment from Novo Nordisk	09:09
Índices: IBEX-35, CAC40, DAX, SMI… 9 índices muy dispares	19/06
US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list	18/06
US judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list	18/06
European shares fall as Middle East tensions weigh; eyes on Fed decision	18/06
Scholar Rock's drug helps Zepbound patients retain more muscle in trial	18/06
U.S. judge upholds FDA's removal of Ozempic, Wegovy from drug shortage list	18/06
Fat, not muscle: Drugmakers in race for next weight-loss breakthrough	18/06
Health Rounds: Weight-loss surgery more effective than drugs in real world study	18/06
CAC40, DAX, SMI, IBEX… 9 indices, 9 verschillen	17/06
WeightWatchers to exit process to cut $1.15 billion debt next week	17/06
Mark Cuban's Cost Plus partners with telehealth firm to offer employers obesity care drugs	17/06
Trump Administration to Consider Pharma Advertising Crackdown	17/06
Trump Administration to Consider Pharma Advertising Crackdown, Bloomberg reports	17/06
DAX, CAC, SMI, IBEX… 9 Indizes, 9 Stimmungen	17/06
CAC40, DAX, SMI, IBEX… 9 indices, 9 ambiances	17/06
Lilly will offer higher doses of Zepbound on its website	16/06
European shares snap five-day losing streak	16/06
European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading	16/06
Lilly to offer highest doses of weight-loss drug Zepbound on website	16/06
Eli Lilly's experimental obesity drug shows over 11% weight loss in early trial	14/06
Global markets live: Tesla, Google, Apple, Novo Nordisk, Boeing…	13/06
Schwächer - "DAX kommt mit blauem Auge davon"	13/06

Non ci sono risultati per questa ricerca

Tutte le notizie Raccomandazione analisti Eventi più importanti Insiders Trascrizioni Comunicati stampa Pubblicazioni ufficiali Altre lingue Idee di trading Articoli MarketScreener Analisi MarketScreener

Filtri

Ultime notizie

Novo Nordisk: nel mirino del fondo Parvus

10 giugno 2025 alle 21:44

NOVO NORDISK : riconoscimento dell'intensificarsi della concorrenza

06 giugno 2025 alle 17:40

Novo licenzia l'amministratore delegato Jorgensen a causa della concorrenza e del prezzo delle azioni

16 maggio 2025 alle 16:26

Miscellanea MarketScreener: deficit commerciale enormi e riacquisti di azioni massicci negli Stati Uniti; la valutazione di Novo Nordisk è in regime di austerità.

08 maggio 2025 alle 10:37